Tomás Segura Selected Research

Tomás Segura Research Topics

Disease

15	Stroke (Strokes) 11/2023 - 01/2003
12	Ischemic Stroke 11/2023 - 08/2010
4	Inflammation (Inflammations) 07/2021 - 01/2008
3	Neoplasms (Cancer) 01/2021 - 09/2015
2	Hypertension (High Blood Pressure) 11/2023 - 09/2015
2	Embolism (Embolus) 11/2023 - 03/2022
2	Hemorrhage 11/2023 - 11/2016
2	Infections 01/2022 - 01/2021
2	Embolic Stroke 01/2022 - 08/2012
2	COVID-19 01/2021 - 10/2020
2	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 12/2020
2	Atherosclerosis 03/2015 - 08/2012
2	Infarction (Infarctions) 08/2010 - 05/2008
2	Brain Ischemia (Cerebral Ischemia) 05/2008 - 01/2008
1	Heart Failure 11/2023
1	Atrial Fibrillation 11/2023
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2022
1	Dyspnea (Shortness of Breath) 01/2022
1	Vasculitis (Vasculitides) 01/2022
1	False Aneurysm (Pseudoaneurysm) 01/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022
1	Aneurysm (Aneurysms) 01/2022
1	Rupture 01/2022
1	Quadriplegia (Spastic Quadriplegia) 01/2022
1	Hematoma 07/2021
1	Obesity 01/2021
1	Neurologic Manifestations (Neurological Manifestations) 01/2021
1	Glioma (Gliomas) 12/2020
1	Astrocytoma (Pilocytic Astrocytoma) 12/2020
1	Multiple Sclerosis 10/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Transient Ischemic Attack 01/2020
1	Thrombosis (Thrombus) 12/2017
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 08/2016
1	Intracranial Vasospasm 08/2016
1	Familial cyclic vomiting syndrome 08/2016
1	Vomiting 08/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2016
1	Hemangioma (Angioma) 09/2015
1	Hypoxia (Hypoxemia) 09/2015
1	Hemangioblastoma 09/2015
1	Gouty Arthritis 05/2014
1	Fabry Disease (Fabry's Disease) 11/2013
1	Gout 08/2010
1	Renal Insufficiency (Renal Failure) 08/2010

Drug/Important Bio-Agent (IBA)

5	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 05/2014
3	AnticoagulantsIBA 11/2023 - 05/2008
3	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 01/2008
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 11/2013
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2016 - 05/2008
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 12/2020
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2015
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2016 - 05/2008
2	Neuroprotective AgentsIBA 05/2014 - 05/2008
2	Uric Acid (Urate)IBA 05/2014 - 08/2010
2	Transcription Factors (Transcription Factor)IBA 03/2010 - 01/2008
1	Vitamin K FDA Link 11/2023
1	N(4)-oleylcytosine arabinosideIBA 11/2023
1	CreatineIBA 11/2023
1	A-factor (Streptomyces)IBA 01/2023
1	CalciumIBA 03/2022
1	Amyloid (Amyloid Fibrils)IBA 07/2021
1	tau Proteins (tau Protein)IBA 07/2021
1	AdipokinesIBA 01/2021
1	PAR-2 ReceptorIBA 01/2021
1	Toll-Like Receptor 4IBA 01/2021
1	zonulinIBA 01/2021
1	FibrinIBA 01/2021
1	NucleotidesIBA 01/2021
1	Messenger RNA (mRNA)IBA 12/2020
1	EnzymesIBA 12/2020
1	DNA-3-methyladenine glycosidase IIIBA 12/2020
1	Alemtuzumab (Campath)FDA Link 10/2020
1	Ferritins (Ferritin)IBA 10/2020
1	Simvastatin (Zocor)FDA LinkGeneric 11/2016
1	MagnesiumIBA 08/2016
1	Omeprazole (Prilosec)FDA LinkGeneric 08/2016
1	ThiazidesIBA 08/2016
1	Clopidogrel (Plavix)FDA Link 01/2016
1	TNF Receptor-Associated Factor 3IBA 01/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2016
1	ElementsIBA 09/2015
1	Proteasome Endopeptidase Complex (Proteasome)IBA 09/2015
1	Propranolol (Inderal)FDA LinkGeneric 09/2015
1	Indicators and Reagents (Reagents)IBA 03/2015
1	AntioxidantsIBA 05/2014
1	Interleukin-6 (Interleukin 6)IBA 11/2013
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2013
1	Cytidine Diphosphate Choline (Citicoline)IBA 07/2012
1	Allopurinol (Remid)FDA LinkGeneric 08/2010
1	Antihypertensive Agents (Antihypertensives)IBA 05/2008

Therapy/Procedure

5	Therapeutics 07/2021 - 01/2008
4	Thrombolytic Therapy 01/2021 - 01/2003
2	Thrombectomy 12/2017 - 09/2017
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 12/2020
1	Stents 09/2017
1	Intravenous Administration 08/2010
1	Aftercare (After-Treatment) 08/2010